World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
80
Citations
32515
World Ranking
16925
National Ranking
8490

Overview

Jonathan G. Goldin is affiliated with the University of California, Los Angeles in the United States. Their research primarily spans the field of Medicine, with a focus on Pulmonary and Respiratory Medicine, where they have contributed extensively.

Their work covers several subfields, including Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging, Epidemiology, and Critical Care and Intensive Care Medicine.

The main topics Jonathan G. Goldin has explored include:

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Systemic Sclerosis and Related Diseases
  • Medical Imaging and Pathology Studies
  • Inflammatory Myopathies and Dermatomyositis
  • Lung Cancer Diagnosis and Treatment
  • Radiomics and Machine Learning in Medical Imaging
  • COVID-19 diagnosis using AI

Among recent papers associated with or relevant to their field, the following stand out:

  • The Role of Chest Imaging in Patient Management During the COVID-19 Pandemic, 2020, CHEST Journal
  • Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial, 2020, The Lancet Respiratory Medicine
  • Tocilizumab Prevents Progression of Early Systemic Sclerosis-Associated Interstitial Lung Disease, 2021, Arthritis & Rheumatology
  • Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis-Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled Trial, 2021, American Journal of Respiratory and Critical Care Medicine
  • Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency, 2024, American Journal of Respiratory and Critical Care Medicine

Jonathan G. Goldin has frequently published in notable venues, including:

  • American Journal of Respiratory and Critical Care Medicine
  • Medical Physics
  • Annals of the Rheumatic Diseases
  • CHEST Journal
  • Neuro-Oncology

Their frequent co-authors include:

  • Grace Hyun J. Kim
  • Elizabeth R. Volkmann
  • Donald P. Tashkin
  • Michael D. Roth
  • Fereidoun Abtin

Best Publications

  • Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing Dialysis

    William G. Goodman;Jonathan Goldin;Beatriz D. Kuizon;Chun Yoon

  • Assessment of coronary artery disease by cardiac computed tomography : A scientific statement from the american heart association committee on cardiovascular imaging and intervention, council on cardiovascular radiology and intervention, and committee on cardiac imaging, council on clinical cardiology

    Matthew J. Budoff;Stephan Achenbach;Roger S. Blumenthal;J. Jeffrey Carr

  • Cyclophosphamide versus placebo in scleroderma lung disease.

    Donald P. Tashkin;Robert Elashoff;Philip J. Clements;Jonathan Goldin

  • The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society

    Geoffrey D. Rubin;Christopher J. Ryerson;Linda B. Haramati;Nicola Sverzellati

  • Chronic obstructive pulmonary disease phenotypes: the future of COPD.

    Mei Lan K. Han;Alvar Agusti;Peter M. Calverley;Bartolome R. Celli

  • The national lung screening trial: Overview and study design

    Constantine A. Gatsonis;Denise R. Aberle;Christine D. Berg;William C. Black

  • A randomized study of endobronchial valves for advanced emphysema.

    Frank C. Sciurba;Armin Ernst;Felix J.F. Herth;Charlie Strange

  • Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper.

    David A Lynch;Nicola Sverzellati;William D Travis;Kevin K Brown

  • Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

    Donald P. Tashkin;Michael D. Roth;Philip J. Clements;Daniel E. Furst

  • Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.

    Dinesh Khanna;Celia J F Lin;Daniel E Furst;Jonathan Goldin

  • Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.

    K. M. Sullivan;E. A. Goldmuntz;L. Keyes-Elstein;P. A. McSweeney

  • Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.

    Donald P. Tashkin;Robert Elashoff;Philip J. Clements;Michael D. Roth

  • Accuracy of PET/CT in Characterization of Solitary Pulmonary Lesions

    Shanna K Kim;Martin Allen-Auerbach;Jonathan Goldin;Barbara J Fueger

  • Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment.

    Whitney B Pope;Hyun J Kim;Jing Huo;Jeffry Alger

  • Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial

    P. L. Shah;D-J Slebos;P. F. G. Cardoso;E. Cetti

  • High-Resolution CT Scan Findings in Patients With Symptomatic Scleroderma-Related Interstitial Lung Disease

    Jonathan G. Goldin;David A. Lynch;Diane C. Strollo;Robert D. Suh

  • SPIROMICS Protocol for Multicenter Quantitative Computed Tomography to Phenotype the Lungs

    Jered P. Sieren;John D. Newell;R. Graham Barr;Eugene R. Bleecker

  • A pattern classification approach to characterizing solitary pulmonary nodules imaged on high resolution CT: preliminary results.

    Michael F. McNitt-Gray;Eric M. Hart;Nathaniel Wyckoff;James W. Sayre

  • Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: Assessment with functional helical thin-section computed tomography

    Jonathan G. Goldin;Donald P. Tashkin;Eric C. Kleerup;Lloyd E. Greaser

  • Patient-specific models for lung nodule detection and surveillance in CT images

    M.S. Brown;M.F. McNitt-Gray;J.G. Goldin;R.D. Suh

Frequent Co-Authors

Donald P. Tashkin
Donald P. Tashkin University of California, Los Angeles
Daniel E. Furst
Daniel E. Furst University of California, Los Angeles
Dinesh Khanna
Dinesh Khanna University of Michigan–Ann Arbor
James Sayre
James Sayre University of California, Los Angeles
Robert Elashoff
Robert Elashoff University of California, Los Angeles
Philip J. Clements
Philip J. Clements University of California, Los Angeles
David A. Lynch
David A. Lynch Children's Hospital of Philadelphia
Virginia D. Steen
Virginia D. Steen Georgetown University
John A. Belperio
John A. Belperio University of California, Los Angeles
Athol U. Wells
Athol U. Wells Imperial College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Medicine opens up a variety of related fields and online learning opportunities. Those interested in healthcare management may consider health administration degrees online, which prepare students for leadership roles across hospitals, clinics, and insurance companies.

For professionals seeking advanced qualifications, a master's in healthcare administration online can offer greater career flexibility and a path to executive positions in the growing healthcare sector. These programs can often be completed entirely online, making them accessible for working adults.

Practicing registered nurses looking to further their expertise might explore some of the cheapest dnp (Doctor of Nursing Practice) programs. This terminal degree can expand opportunities in clinical practice, leadership, and education.

Finally, students interested in medication management and pharmaceutical sciences may consider pursuing accredited pharmd online programs. These degrees equip graduates for diverse roles in pharmacies, hospitals, research centers, and the pharmaceutical industry.

Best Scientists Citing Jonathan G. Goldin

Trending Scientists

Recently Published Articles